Flaharty Asset Management’s Biogen BIIB Stock Holding History

Flaharty Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-861	Closed	-$204K	–	72
2019 Q1	$204K	Buy	+861	New	+$271K	0.08%	79

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Flaharty Asset Management's BIIB Position: Q2 2019 in Review

Flaharty Asset Management sold out of Biogen (BIIB) in Q2 2019, closing a stake of 861 shares — an estimated $204K sold.

Flaharty Asset Management first reported a position in BIIB in Q1 2019 and held it in 1 quarter. The position peaked at $204K in Q1 2019. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Flaharty Asset Management reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
Flaharty Asset Management sold 861 Biogen shares in Q2 2019, an estimated $204K.
Flaharty Asset Management first reported a position in Biogen in Q1 2019 and held it in 1 quarter.
Flaharty Asset Management's Biogen position peaked at $204K in Q1 2019.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Flaharty Asset Management's 13F filing for Q2 2019, filed 30 Jul 2019.